Spero Therapeutics
Clinical trials sponsored by Spero Therapeutics, explained in plain language.
-
New antibiotic candidate targets stubborn lung infection
Disease control CompletedThis study tested an experimental drug called SPR720 in 25 adults with a chronic lung infection caused by Mycobacterium avium complex (MAC). The goal was to see if the drug could reduce bacteria in sputum and improve symptoms compared to a placebo. Participants took the drug or p…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 17, 2026 11:23 UTC
-
Could a pill replace the IV for serious UTIs? new study investigates
Disease control CompletedThis study tested an oral antibiotic (tebipenem pivoxil hydrobromide) against a standard IV antibiotic in 1690 hospitalized adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the oral drug works as well as the IV treatment in curin…
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:02 UTC